P19086
Gene name |
GNAZ |
Protein name |
Guanine nucleotide-binding protein G |
Names |
z subunit alpha , G, x alpha chain , Gz-alpha |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:2781 |
EC number |
|
Protein Class |
|

Descriptions
Autoinhibitory domains (AIDs)
Target domain |
185-349 (Ras-like domain) |
Relief mechanism |
Ligand binding, Partner binding |
Assay |
|
Accessory elements
No accessory elements
References
- Goricanec D et al. (2016) "Conformational dynamics of a G-protein α subunit is tightly regulated by nucleotide binding", Proceedings of the National Academy of Sciences of the United States of America, 113, E3629-38
- Coleman DE et al. (1999) "Structure of Gialpha1.GppNHp, autoinhibition in a galpha protein-substrate complex", The Journal of biological chemistry, 274, 16669-72
- Lutz S et al. (2007) "Structure of Galphaq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs", Science (New York, N.Y.), 318, 1923-7
Autoinhibited structure

Activated structure

2 structures for P19086
Entry ID | Method | Resolution | Chain | Position | Source |
---|---|---|---|---|---|
8DZS | EM | 265 A | B | 30-355 | PDB |
AF-P19086-F1 | Predicted | AlphaFoldDB |
264 variants for P19086
Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
---|---|---|---|---|---|
rs773947794 | 4 | R>Q | No |
ExAC TOPMed gnomAD |
|
COSM3552500 rs189374840 |
4 | R>W | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic 1000Genomes ExAC NCI-TCGA TOPMed gnomAD |
TCGA novel | 5 | Q>* | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No | NCI-TCGA |
COSM3309365 rs2069104142 |
9 | E>K | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic TOPMed |
COSM4102956 | 10 | K>N | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs772805782 | 11 | E>A | No |
ExAC TOPMed gnomAD |
|
rs866852399 | 13 | A>D | No | Ensembl | |
rs760505008 | 14 | R>Q | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
ExAC NCI-TCGA TOPMed gnomAD |
rs753636007 | 15 | R>Q | No |
ExAC TOPMed gnomAD |
|
COSM726191 rs766030793 |
15 | R>W | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic ExAC NCI-TCGA gnomAD |
rs898310493 | 17 | R>Q | No | TOPMed | |
rs1188639934 | 17 | R>W | No | gnomAD | |
rs879182489 | 20 | D>A | No | Ensembl | |
rs995461477 | 20 | D>N | No | Ensembl | |
TCGA novel | 20 | D>Y | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs1028260962 | 21 | R>C | No | gnomAD | |
rs200927041 | 21 | R>H | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs1462919254 | 24 | R>C | No |
TOPMed gnomAD |
|
rs781475556 | 24 | R>H | No |
ExAC TOPMed gnomAD |
|
rs1329272614 | 29 | R>Q | No | gnomAD | |
rs1432707029 | 31 | R>C | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA TOPMed gnomAD |
rs756359282 | 32 | R>C | No |
ExAC TOPMed gnomAD |
|
rs1339551949 | 32 | R>H | No |
TOPMed gnomAD |
|
COSM3842272 rs974996242 |
33 | E>K | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA TOPMed gnomAD |
rs2069106385 | 35 | K>M | No | gnomAD | |
COSM4102957 | 35 | K>R | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
TCGA novel | 37 | L>H | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs1190591240 | 41 | T>A | No | TOPMed | |
rs267606186 | 43 | N>S | No | Ensembl | |
COSM1032555 | 45 | G>C | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
COSM1565995 rs2069107342 |
50 | V>I | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic TOPMed |
rs2069107578 | 53 | M>I | No | gnomAD | |
rs1218480736 | 53 | M>V | No | gnomAD | |
rs2069107690 | 57 | H>P | No | Ensembl | |
rs1243088869 | 58 | S>G | No | gnomAD | |
COSM1415126 | 58 | S>N | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
COSM726190 | 59 | G>C | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1569172679 | 59 | G>S | No | TOPMed | |
COSM1032556 | 60 | G>D | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs771539649 | 60 | G>S | No |
ExAC TOPMed gnomAD |
|
rs1162115413 | 62 | N>K | No | gnomAD | |
rs2146315927 | 64 | E>G | No | Ensembl | |
rs17853741 | 65 | A>S | No | gnomAD | |
rs17853741 | 65 | A>T | No | gnomAD | |
rs2069108356 | 70 | K>T | No | TOPMed | |
rs1318832362 | 72 | L>I | No | gnomAD | |
rs2069109116 | 74 | I>M | No | Ensembl | |
rs1359718743 | 74 | I>V | No | gnomAD | |
rs988956804 | 75 | Y>H | No |
TOPMed gnomAD |
|
rs1276612366 | 76 | N>D | No | gnomAD | |
rs147402483 | 78 | I>L | No |
ESP ExAC TOPMed gnomAD |
|
rs147402483 | 78 | I>V | No |
ESP ExAC TOPMed gnomAD |
|
rs1354293183 | 79 | D>N | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA gnomAD |
COSM142289 rs1331938640 |
80 | S>L | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA TOPMed |
rs761943894 | 82 | T>I | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
ExAC NCI-TCGA gnomAD |
rs761943894 | 82 | T>N | No |
ExAC gnomAD |
|
rs1601792664 | 82 | T>P | No | Ensembl | |
rs1485802752 | 83 | R>C | No |
TOPMed gnomAD |
|
rs1485802752 | 83 | R>G | No |
TOPMed gnomAD |
|
rs556083506 | 86 | R>P | No | 1000Genomes | |
rs556083506 | 86 | R>Q | No | 1000Genomes | |
COSM4102959 rs1366225244 |
86 | R>W | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA TOPMed gnomAD |
rs1379606183 | 89 | A>T | No | gnomAD | |
rs780469417 | 90 | A>S | No |
ExAC TOPMed gnomAD |
|
rs780469417 | 90 | A>T | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
ExAC NCI-TCGA TOPMed gnomAD |
rs2146316286 | 93 | I>S | No | Ensembl | |
rs574541604 | 94 | D>N | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs938228823 | 95 | F>L | No |
TOPMed gnomAD |
|
rs1333699803 | 96 | H>Y | No |
TOPMed gnomAD |
|
rs748545161 | 97 | N>D | No |
ExAC TOPMed gnomAD |
|
rs1601792822 | 97 | N>T | No | Ensembl | |
rs2146316392 | 99 | D>A | No | Ensembl | |
rs1310716515 | 99 | D>E | No | gnomAD | |
rs1458257062 | 99 | D>N | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA gnomAD |
rs777109231 | 100 | R>C | No |
ExAC TOPMed gnomAD |
|
rs746553162 | 100 | R>H | No |
ExAC TOPMed gnomAD |
|
rs746553162 COSM726189 |
100 | R>L | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic ExAC NCI-TCGA TOPMed gnomAD |
rs1346089765 | 101 | A>T | No | gnomAD | |
rs2069112311 | 102 | Y>C | No | TOPMed | |
rs1253604242 COSM1032557 |
103 | D>N | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA gnomAD |
rs143839657 | 104 | A>S | No |
1000Genomes ESP ExAC TOPMed gnomAD |
|
rs143839657 | 104 | A>T | No |
1000Genomes ESP ExAC TOPMed gnomAD |
|
rs199547495 | 104 | A>V | No |
1000Genomes TOPMed gnomAD |
|
rs2069113107 | 107 | L>I | No | Ensembl | |
rs1172258202 | 110 | L>R | No | gnomAD | |
rs1400331956 | 111 | T>M | No |
TOPMed gnomAD |
|
rs1332143513 | 112 | G>A | No | gnomAD | |
rs1332143513 | 112 | G>D | No | gnomAD | |
COSM3912462 rs1376170210 |
113 | P>S | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA TOPMed gnomAD |
rs1315151887 | 114 | A>T | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA gnomAD |
rs755263774 | 116 | S>N | No |
ExAC gnomAD |
|
rs1008145135 | 119 | E>K | No | gnomAD | |
rs758676841 | 122 | P>R | No | Ensembl | |
rs1231691438 | 122 | P>S | No | TOPMed | |
rs1019323839 | 123 | E>K | No | gnomAD | |
rs1199757798 | 126 | G>C | No |
TOPMed gnomAD |
|
rs1199757798 | 126 | G>S | No |
TOPMed gnomAD |
|
rs2069115288 | 128 | M>L | No | TOPMed | |
rs2069115419 | 129 | R>Q | No | TOPMed | |
rs745469780 | 130 | R>Q | No |
ExAC gnomAD |
|
rs1432454071 | 130 | R>W | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA gnomAD |
rs796810282 | 131 | L>I | No | gnomAD | |
rs1467385561 | 133 | A>T | No | gnomAD | |
COSM4102960 | 133 | A>V | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs17852409 | 135 | P>Q | No | TOPMed | |
rs1399705899 | 136 | G>W | No | gnomAD | |
COSM4102961 | 137 | A>V | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs775094245 | 139 | A>S | No |
ExAC gnomAD |
|
rs775094245 | 139 | A>T | No |
ExAC gnomAD |
|
rs951767417 COSM1307997 |
143 | R>H | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA TOPMed gnomAD |
rs1299646054 | 144 | S>F | No | gnomAD | |
rs1601793263 | 145 | S>G | No | TOPMed | |
rs1601793263 | 145 | S>R | No | TOPMed | |
rs1328521572 | 145 | S>R | No |
TOPMed gnomAD |
|
TCGA novel | 146 | E>G | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No | NCI-TCGA |
rs2069116391 | 146 | E>K | No | Ensembl | |
rs1601793283 | 147 | Y>D | No | Ensembl | |
rs1218883952 | 148 | H>P | No | gnomAD | |
rs1010010129 | 149 | L>V | No |
TOPMed gnomAD |
|
rs148874764 | 151 | D>N | No | Ensembl | |
rs1237639616 | 153 | A>T | No | TOPMed | |
rs200414454 | 153 | A>V | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs1488125051 | 155 | Y>H | No | gnomAD | |
rs1207921295 | 158 | N>D | No | gnomAD | |
rs766508619 | 158 | N>K | No |
ExAC TOPMed gnomAD |
|
rs1412507158 | 159 | D>E | No |
TOPMed gnomAD |
|
rs377139627 | 159 | D>N | No |
ESP ExAC TOPMed gnomAD |
|
rs377139627 | 159 | D>Y | No |
ESP ExAC TOPMed gnomAD |
|
TCGA novel | 162 | R>C | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs2069117466 | 162 | R>H | No | TOPMed | |
rs918141111 | 163 | I>V | No |
TOPMed gnomAD |
|
COSM4102962 rs765527032 |
164 | A>T | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic ExAC NCI-TCGA gnomAD |
rs1601793391 | 165 | A>T | No |
TOPMed gnomAD |
|
COSM3693965 | 165 | A>V | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1158510415 | 166 | A>T | No |
TOPMed gnomAD |
|
rs2069117947 | 166 | A>V | No | TOPMed | |
rs1475853215 | 167 | D>G | No |
TOPMed gnomAD |
|
rs1569173107 | 167 | D>N | No | TOPMed | |
rs1895286336 | 168 | Y>C | No | TOPMed | |
rs2069118392 | 171 | T>S | No | TOPMed | |
rs2069118493 | 172 | V>I | No |
TOPMed gnomAD |
|
rs1457866450 | 173 | E>K | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA TOPMed gnomAD |
rs1485440291 | 175 | I>M | No |
TOPMed gnomAD |
|
rs2069119077 COSM4102963 |
175 | I>T | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic TOPMed |
rs2069118957 | 175 | I>V | No | TOPMed | |
rs2069119286 | 177 | R>C | No | Ensembl | |
rs369848697 | 177 | R>H | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
ESP ExAC NCI-TCGA TOPMed gnomAD |
rs369848697 | 177 | R>L | No |
ESP ExAC TOPMed gnomAD |
|
COSM3552505 | 178 | S>F | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1297276620 | 180 | D>E | No | gnomAD | |
rs866909344 | 181 | M>V | No | Ensembl | |
rs1234684162 | 183 | T>M | No | gnomAD | |
rs1242546685 | 185 | I>V | No | gnomAD | |
rs1262387602 | 188 | N>K | No |
TOPMed gnomAD |
|
rs1227709638 | 189 | K>R | No |
TOPMed gnomAD |
|
rs1215609247 | 191 | T>I | No | gnomAD | |
rs755736229 | 196 | T>I | No |
ExAC gnomAD |
|
rs2069121219 | 198 | K>N | No | Ensembl | |
rs2069121283 | 200 | V>G | No | TOPMed | |
COSM1208403 | 201 | D>G | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1294568586 | 201 | D>N | No | TOPMed | |
rs749025428 | 202 | V>M | No |
ExAC gnomAD |
|
rs1423293042 | 203 | G>A | No |
TOPMed gnomAD |
|
rs1423293042 | 203 | G>E | No |
TOPMed gnomAD |
|
COSM1415127 rs752075537 |
205 | Q>A | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA |
TCGA novel | 205 | Q>G | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No | NCI-TCGA |
COSM3309388 | 205 | Q>R | Variant assessed as Somatic; HIGH impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs2069122359 | 207 | S>L | No | gnomAD | |
rs2069122601 | 209 | R>C | No | TOPMed | |
COSM4102964 | 209 | R>H | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1158434104 | 215 | C>Y | No | gnomAD | |
rs1303018992 | 217 | E>K | No | gnomAD | |
rs1303018992 | 217 | E>Q | No | gnomAD | |
rs775837880 | 219 | V>I | No |
ExAC TOPMed gnomAD |
|
COSM1032558 | 221 | A>S | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
COSM1032559 | 221 | A>V | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
COSM4102965 | 223 | I>V | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
TCGA novel | 224 | F>V | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs1309128778 | 224 | F>Y | No | gnomAD | |
rs2069123967 | 225 | C>F | No | TOPMed | |
rs2069124183 | 226 | V>M | No | TOPMed | |
rs768056901 | 230 | G>C | No |
ExAC TOPMed gnomAD |
|
rs768056901 | 230 | G>S | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
ExAC NCI-TCGA TOPMed gnomAD |
rs144435757 | 231 | Y>* | No |
1000Genomes ESP ExAC TOPMed gnomAD |
|
TCGA novel | 232 | D>N | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs199896240 | 233 | L>V | No |
1000Genomes ESP ExAC TOPMed gnomAD |
|
rs1569173304 | 234 | K>Q | No | gnomAD | |
rs2069125430 | 240 | Q>H | No | gnomAD | |
rs777845926 | 243 | R>W | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
ExAC NCI-TCGA gnomAD |
COSM5742060 rs1365180134 |
249 | R>C | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA TOPMed gnomAD |
COSM4687426 rs1221941233 |
249 | R>H | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA gnomAD |
COSM4102966 | 254 | I>M | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs2146403657 | 256 | N>Y | No | Ensembl | |
rs1257765665 | 261 | I>V | No |
TOPMed gnomAD |
|
rs374781793 | 265 | L>F | No |
ESP TOPMed gnomAD |
|
rs1289265847 | 267 | L>F | No | TOPMed | |
rs1222896224 | 270 | N>K | No | gnomAD | |
rs1411935722 | 271 | K>R | No |
TOPMed gnomAD |
|
rs2070079356 | 272 | K>T | No | Ensembl | |
rs2070079449 | 273 | D>Y | No | Ensembl | |
rs749371797 | 274 | L>P | No |
ExAC gnomAD |
|
rs2070079698 | 277 | E>D | No | Ensembl | |
COSM1751755 | 277 | E>Q | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs1401045732 | 278 | K>E | No | gnomAD | |
rs768904384 | 280 | R>C | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
ExAC NCI-TCGA TOPMed gnomAD |
rs774616807 | 280 | R>H | No |
ExAC TOPMed gnomAD |
|
rs772358501 | 281 | R>C | No |
ExAC gnomAD |
|
rs773581427 | 281 | R>H | No |
ExAC TOPMed gnomAD |
|
rs761195937 | 282 | I>V | No |
ExAC gnomAD |
|
rs2070080304 | 283 | P>A | No | TOPMed | |
rs759015647 | 286 | I>V | No |
ExAC gnomAD |
|
rs2070080689 | 289 | P>S | No | gnomAD | |
rs758126196 | 290 | E>D | No |
ExAC TOPMed gnomAD |
|
rs148799264 | 290 | E>K | No |
ESP ExAC TOPMed gnomAD |
|
rs148799264 | 290 | E>Q | No |
ESP ExAC TOPMed gnomAD |
|
rs763921035 | 292 | K>Q | No |
ExAC gnomAD |
|
rs372407179 | 292 | K>R | No |
ESP ExAC TOPMed gnomAD |
|
TCGA novel | 292 | K>T | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs1268518787 | 294 | Q>H | No | gnomAD | |
rs940428715 | 296 | T>A | No | Ensembl | |
rs1214420728 | 296 | T>M | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA gnomAD |
COSM4102967 | 297 | Y>F | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs749377481 | 298 | E>K | No |
ExAC TOPMed gnomAD |
|
rs995670740 | 299 | E>K | No | Ensembl | |
rs2146404015 | 300 | A>G | No | Ensembl | |
rs545366122 | 301 | A>T | No |
ExAC TOPMed gnomAD |
|
rs773587124 | 302 | V>I | No |
ExAC TOPMed |
|
rs773587124 | 302 | V>L | No |
ExAC TOPMed |
|
rs2070082580 | 303 | Y>N | No | gnomAD | |
rs368759895 | 306 | R>Q | No |
ESP ExAC TOPMed gnomAD |
|
rs1267826319 | 306 | R>W | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA TOPMed gnomAD |
rs200744011 | 307 | Q>H | No |
ExAC TOPMed gnomAD |
|
rs1601842735 | 308 | F>V | No | Ensembl | |
rs111937053 | 309 | E>* | No | Ensembl | |
rs777062312 | 309 | E>G | No |
ExAC gnomAD |
|
rs111937053 | 309 | E>Q | No | Ensembl | |
COSM4102968 | 310 | D>N | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA Cosmic |
rs2070083422 | 311 | L>M | No | Ensembl | |
rs764771187 | 312 | N>S | No |
ExAC gnomAD |
|
rs775149885 COSM5859007 |
313 | R>C | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic ExAC NCI-TCGA TOPMed gnomAD |
rs762641601 COSM4102969 |
313 | R>H | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic ExAC NCI-TCGA TOPMed gnomAD |
rs1268875615 | 314 | N>H | No | Ensembl | |
rs1399649296 | 316 | E>A | No | gnomAD | |
rs1399649296 | 316 | E>V | No | gnomAD | |
rs2070084557 | 318 | K>N | No | Ensembl | |
rs1230402052 | 318 | K>Q | No | TOPMed | |
rs2070084468 | 318 | K>T | No | Ensembl | |
rs1601842799 COSM3552506 |
319 | E>K | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic Ensembl |
rs1342383509 | 320 | I>F | No | gnomAD | |
rs1601842820 | 321 | Y>S | No | Ensembl | |
rs757062183 | 322 | S>C | No |
ExAC gnomAD |
|
rs1601842837 | 325 | T>P | No | Ensembl | |
rs1287229592 | 327 | A>T | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA gnomAD |
rs569868909 | 329 | D>N | No |
1000Genomes ExAC TOPMed gnomAD |
|
rs2070085996 | 331 | S>G | No | TOPMed | |
rs2070086269 | 337 | F>I | No | TOPMed | |
rs777904768 | 338 | D>N | No |
ExAC TOPMed gnomAD |
|
rs1379507136 COSM6038529 |
339 | A>T | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
NCI-TCGA Cosmic NCI-TCGA TOPMed gnomAD |
rs2146404480 | 339 | A>V | No | 1000Genomes | |
rs776278844 | 343 | V>I | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No |
Ensembl NCI-TCGA |
TCGA novel | 344 | I>T | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
TCGA novel | 345 | I>M | Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] | No | NCI-TCGA |
rs1569188293 | 346 | Q>L | No | Ensembl | |
rs2070087332 | 348 | N>H | No | TOPMed |
No associated diseases with P19086
No regional properties for P19086
Type | Name | Position | InterPro Accession |
---|---|---|---|
No domain, repeats, and functional sites for P19086 |
7 GO annotations of cellular component
Name | Definition |
---|---|
cell body | The portion of a cell bearing surface projections such as axons, dendrites, cilia, or flagella that includes the nucleus, but excludes all cell projections. |
cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
dendrite | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
endoplasmic reticulum | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). |
heterotrimeric G-protein complex | Any of a family of heterotrimeric GTP-binding and hydrolyzing proteins; they belong to a superfamily of GTPases that includes monomeric proteins such as EF-Tu and RAS. Heterotrimeric G-proteins consist of three subunits; the alpha subunit contains the guanine nucleotide binding site and possesses GTPase activity; the beta and gamma subunits are tightly associated and function as a beta-gamma heterodimer; extrinsic plasma membrane proteins (cytoplasmic face) that function as a complex to transduce signals from G protein-coupled receptors to an effector protein. |
nuclear envelope | The double lipid bilayer enclosing the nucleus and separating its contents from the rest of the cytoplasm; includes the intermembrane space, a gap of width 20-40 nm (also called the perinuclear space). |
plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
7 GO annotations of molecular function
Name | Definition |
---|---|
adenylate cyclase inhibitor activity | Binds to and decreases the activity adenylate cyclase. |
G protein-coupled receptor binding | Binding to a G protein-coupled receptor. |
G protein-coupled serotonin receptor binding | Binding to a metabotropic serotonin receptor. |
G-protein beta/gamma-subunit complex binding | Binding to a complex of G-protein beta/gamma subunits. |
GTP binding | Binding to GTP, guanosine triphosphate. |
GTPase activity | Catalysis of the reaction |
metal ion binding | Binding to a metal ion. |
5 GO annotations of biological process
Name | Definition |
---|---|
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the inhibition of adenylyl cyclase activity and a subsequent decrease in the intracellular concentration of cyclic AMP (cAMP). |
adenylate cyclase-modulating G protein-coupled receptor signaling pathway | A G protein-coupled receptor signaling pathway in which the signal is transmitted via the activation or inhibition of adenylyl cyclase activity and a subsequent change in the intracellular concentration of cyclic AMP (cAMP). |
G protein-coupled receptor signaling pathway | The series of molecular signals initiated by a ligand binding to its receptor, in which the activated receptor promotes the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, and ends with regulation of a downstream cellular process. The pathway can start from the plasma membrane, Golgi or nuclear membrane. |
G protein-coupled serotonin receptor signaling pathway | The series of molecular signals generated as a consequence of a G protein-coupled serotonin receptor binding to one of its physiological ligands. |
negative regulation of insulin secretion | Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of insulin. |
61 homologous proteins in AiPD
UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
---|---|---|---|---|
P63097 | GNAI1 | Guanine nucleotide-binding protein G | Bos taurus (Bovine) | SS |
P0C7Q4 | GNAT3 | Guanine nucleotide-binding protein G | Bos taurus (Bovine) | SS |
P04696 | GNAT2 | Guanine nucleotide-binding protein G | Bos taurus (Bovine) | SS |
P04695 | GNAT1 | Guanine nucleotide-binding protein G | Bos taurus (Bovine) | SS |
P08239 | GNAO1 | Guanine nucleotide-binding protein G | Bos taurus (Bovine) | SS |
P50147 | GNAI2 | Guanine nucleotide-binding protein G | Gallus gallus (Chicken) | SS |
P50146 | GNAI1 | Guanine nucleotide-binding protein G | Gallus gallus (Chicken) | SS |
P20353 | Galphai | G protein alpha i subunit | Drosophila melanogaster (Fruit fly) | SS |
P16378 | Galphao | G protein alpha o subunit | Drosophila melanogaster (Fruit fly) | SS |
P25157 | cta | Guanine nucleotide-binding protein subunit alpha homolog | Drosophila melanogaster (Fruit fly) | SS |
A8MTJ3 | GNAT3 | Guanine nucleotide-binding protein G | Homo sapiens (Human) | SS |
P08754 | GNAI3 | Guanine nucleotide-binding protein G | Homo sapiens (Human) | SS |
P11488 | GNAT1 | Guanine nucleotide-binding protein G | Homo sapiens (Human) | SS |
P19087 | GNAT2 | Guanine nucleotide-binding protein G | Homo sapiens (Human) | SS |
P29992 | GNA11 | Guanine nucleotide-binding protein subunit alpha-11 | Homo sapiens (Human) | SS |
P30679 | GNA15 | Guanine nucleotide-binding protein subunit alpha-15 | Homo sapiens (Human) | SS |
P50148 | GNAQ | Guanine nucleotide-binding protein G | Homo sapiens (Human) | SS |
O95837 | GNA14 | Guanine nucleotide-binding protein subunit alpha-14 | Homo sapiens (Human) | SS |
Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | Homo sapiens (Human) | SS |
Q03113 | GNA12 | Guanine nucleotide-binding protein subunit alpha-12 | Homo sapiens (Human) | SS |
P38405 | GNAL | Guanine nucleotide-binding protein G | Homo sapiens (Human) | SS |
P04899 | GNAI2 | Guanine nucleotide-binding protein G | Homo sapiens (Human) | SS |
P63096 | GNAI1 | Guanine nucleotide-binding protein G | Homo sapiens (Human) | EV |
P09471 | GNAO1 | Guanine nucleotide-binding protein G | Homo sapiens (Human) | SS |
Q9DC51 | Gnai3 | Guanine nucleotide-binding protein G | Mus musculus (Mouse) | SS |
P27600 | Gna12 | Guanine nucleotide-binding protein subunit alpha-12 | Mus musculus (Mouse) | SS |
P20612 | Gnat1 | Guanine nucleotide-binding protein G | Mus musculus (Mouse) | SS |
P27601 | Gna13 | Guanine nucleotide-binding protein subunit alpha-13 | Mus musculus (Mouse) | SS |
Q3V3I2 | Gnat3 | Guanine nucleotide-binding protein G | Mus musculus (Mouse) | SS |
P50149 | Gnat2 | Guanine nucleotide-binding protein G | Mus musculus (Mouse) | SS |
P08752 | Gnai2 | Guanine nucleotide-binding protein G | Mus musculus (Mouse) | SS |
B2RSH2 | Gnai1 | Guanine nucleotide-binding protein G | Mus musculus (Mouse) | SS |
P18872 | Gnao1 | Guanine nucleotide-binding protein G | Mus musculus (Mouse) | SS |
O70443 | Gnaz | Guanine nucleotide-binding protein G | Mus musculus (Mouse) | SS |
P93564 | GPA1 | Guanine nucleotide-binding protein alpha-1 subunit | Solanum tuberosum (Potato) | SS |
Q63210 | Gna12 | Guanine nucleotide-binding protein subunit alpha-12 | Rattus norvegicus (Rat) | SS |
P29348 | Gnat3 | Guanine nucleotide-binding protein G | Rattus norvegicus (Rat) | SS |
P04897 | Gnai2 | Guanine nucleotide-binding protein G | Rattus norvegicus (Rat) | SS |
P59215 | Gnao1 | Guanine nucleotide-binding protein G | Rattus norvegicus (Rat) | SS |
P08753 | Gnai3 | Guanine nucleotide-binding protein G | Rattus norvegicus (Rat) | SS |
Q6Q7Y5 | Gna13 | Guanine nucleotide-binding protein subunit alpha-13 | Rattus norvegicus (Rat) | SS |
P19627 | Gnaz | Guanine nucleotide-binding protein G | Rattus norvegicus (Rat) | SS |
Q0DJ33 | GPA1 | Guanine nucleotide-binding protein alpha-1 subunit | Oryza sativa subsp. japonica (Rice) | SS |
P51875 | goa-1 | Guanine nucleotide-binding protein G | Caenorhabditis elegans | SS |
Q18434 | odr-3 | Guanine nucleotide-binding protein alpha-17 subunit | Caenorhabditis elegans | SS |
Q9BIG4 | gpa-10 | Guanine nucleotide-binding protein alpha-10 subunit | Caenorhabditis elegans | PR |
P28052 | gpa-3 | Guanine nucleotide-binding protein alpha-3 subunit | Caenorhabditis elegans | SS |
Q9XTB2 | gpa-13 | Guanine nucleotide-binding protein alpha-13 subunit | Caenorhabditis elegans | SS |
Q9BIG5 | gpa-4 | Guanine nucleotide-binding protein alpha-4 subunit | Caenorhabditis elegans | SS |
P28051 | gpa-1 | Guanine nucleotide-binding protein alpha-1 subunit | Caenorhabditis elegans | SS |
Q9N2V6 | gpa-16 | Guanine nucleotide-binding protein alpha-16 subunit | Caenorhabditis elegans | SS |
P91907 | gpa-15 | Guanine nucleotide-binding protein alpha-15 subunit | Caenorhabditis elegans | SS |
Q20907 | gpa-8 | Guanine nucleotide-binding protein alpha-8 subunit | Caenorhabditis elegans | PR |
Q21917 | gpa-7 | Guanine nucleotide-binding protein alpha-7 subunit | Caenorhabditis elegans | SS |
Q93743 | gpa-6 | Guanine nucleotide-binding protein alpha-6 subunit | Caenorhabditis elegans | SS |
O76584 | gpa-11 | Guanine nucleotide-binding protein alpha-11 subunit | Caenorhabditis elegans | SS |
P49084 | GPA1 | Guanine nucleotide-binding protein alpha-1 subunit | Glycine max (Soybean) (Glycine hispida) | SS |
P93163 | GPA2 | Guanine nucleotide-binding protein alpha-2 subunit | Glycine max (Soybean) (Glycine hispida) | SS |
O80462 | XLG1 | Extra-large guanine nucleotide-binding protein 1 | Arabidopsis thaliana (Mouse-ear cress) | PR |
P18064 | GPA1 | Guanine nucleotide-binding protein alpha-1 subunit | Arabidopsis thaliana (Mouse-ear cress) | SS |
P26981 | GPA1 | Guanine nucleotide-binding protein alpha-1 subunit | Solanum lycopersicum (Tomato) (Lycopersicon esculentum) | SS |
10 | 20 | 30 | 40 | 50 | 60 |
MGCRQSSEEK | EAARRSRRID | RHLRSESQRQ | RREIKLLLLG | TSNSGKSTIV | KQMKIIHSGG |
70 | 80 | 90 | 100 | 110 | 120 |
FNLEACKEYK | PLIIYNAIDS | LTRIIRALAA | LRIDFHNPDR | AYDAVQLFAL | TGPAESKGEI |
130 | 140 | 150 | 160 | 170 | 180 |
TPELLGVMRR | LWADPGAQAC | FSRSSEYHLE | DNAAYYLNDL | ERIAAADYIP | TVEDILRSRD |
190 | 200 | 210 | 220 | 230 | 240 |
MTTGIVENKF | TFKELTFKMV | DVGGQRSERK | KWIHCFEGVT | AIIFCVELSG | YDLKLYEDNQ |
250 | 260 | 270 | 280 | 290 | 300 |
TSRMAESLRL | FDSICNNNWF | INTSLILFLN | KKDLLAEKIR | RIPLTICFPE | YKGQNTYEEA |
310 | 320 | 330 | 340 | 350 | |
AVYIQRQFED | LNRNKETKEI | YSHFTCATDT | SNIQFVFDAV | TDVIIQNNLK | YIGLC |